38180612|t|Fluvoxamine Exerts Sigma-1R to Rescue Autophagy via Pom121-Mediated Nucleocytoplasmic Transport of TFEB.
38180612|a|Expansion of the GGGGCC-RNA repeat is a known cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), which currently have no cure. Recent studies have indicated the activation of Sigma-1 receptor plays an important role in providing neuroprotection, especially in ALS and Alzheimer's disease. Nevertheless, the mechanisms underlying Sigma-1R activation and its effect on (G4C2)n-RNA-induced cell death remain unclear. In this study, we demonstrated that fluvoxamine is a Sigma-1R agonist that can increase chaperone activity and stabilize the protein expression of Pom121 in (G4C2)31-RNA-expressing NSC34 cells, leading to increased colocalization at the nuclear envelope. Interestingly, fluvoxamine treatment increased Pom121 protein expression without affecting transcription. In C9orf72-ALS, the nuclear translocation of TFEB autophagy factor decreased owing to nucleocytoplasmic transport defects. Our results showed that pretreatment of NSC34 cells with fluvoxamine promoted the shuttling of TFEB into the nucleus and elevated the expression of LC3-II compared to the overexpression of (G4C2)31-RNA alone. Additionally, even when used alone, fluvoxamine increases Pom121 expression and TFEB translocation. To summarize, fluvoxamine may act as a promising repurposed medicine for patients with C9orf72-ALS, as it stabilizes the nucleoporin Pom121 and promotes the translocation of TFEB in (G4C2)31-RNA-expressing NSC34 cells.
38180612	0	11	Fluvoxamine	Chemical	MESH:D016666
38180612	19	27	Sigma-1R	Gene	10280
38180612	52	58	Pom121	Gene	107939
38180612	99	103	TFEB	Gene	7942
38180612	160	189	amyotrophic lateral sclerosis	Disease	MESH:D000690
38180612	191	194	ALS	Disease	MESH:D000690
38180612	200	223	frontotemporal dementia	Disease	MESH:D057180
38180612	225	228	FTD	Disease	MESH:D057180
38180612	309	325	Sigma-1 receptor	Gene	18391
38180612	394	397	ALS	Disease	MESH:D000690
38180612	402	421	Alzheimer's disease	Disease	MESH:D000544
38180612	463	471	Sigma-1R	Gene	18391
38180612	584	595	fluvoxamine	Chemical	MESH:D016666
38180612	601	609	Sigma-1R	Gene	10280
38180612	695	701	Pom121	Gene	107939
38180612	729	734	NSC34	CellLine	CVCL:D356
38180612	818	829	fluvoxamine	Chemical	MESH:D016666
38180612	850	856	Pom121	Gene	107939
38180612	912	919	C9orf72	Gene	203228
38180612	920	923	ALS	Disease	MESH:D000690
38180612	954	958	TFEB	Gene	7942
38180612	1072	1077	NSC34	CellLine	CVCL:D356
38180612	1089	1100	fluvoxamine	Chemical	MESH:D016666
38180612	1127	1131	TFEB	Gene	21425
38180612	1277	1288	fluvoxamine	Chemical	MESH:D016666
38180612	1299	1305	Pom121	Gene	107939
38180612	1321	1325	TFEB	Gene	7942
38180612	1355	1366	fluvoxamine	Chemical	MESH:D016666
38180612	1414	1422	patients	Species	9606
38180612	1428	1435	C9orf72	Gene	203228
38180612	1436	1439	ALS	Disease	MESH:D000690
38180612	1462	1473	nucleoporin	Gene	66070
38180612	1474	1480	Pom121	Gene	107939
38180612	1515	1519	TFEB	Gene	21425
38180612	1547	1552	NSC34	CellLine	CVCL:D356
38180612	Association	MESH:D000690	18391
38180612	Negative_Correlation	MESH:D016666	MESH:D000690
38180612	Association	MESH:D016666	7942
38180612	Association	10280	7942
38180612	Association	MESH:D000690	203228
38180612	Positive_Correlation	MESH:D016666	21425
38180612	Association	MESH:D000544	18391
38180612	Positive_Correlation	MESH:D016666	107939
38180612	Association	MESH:D000690	7942
38180612	Association	107939	7942
38180612	Positive_Correlation	MESH:D016666	10280

